Manuela Cervelli

Prof. Manuela Cervelli

Dipartimento di Scienze, Università degli studi Roma Tre, 00154 Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Journal of Molecular Evolution
Verified
Journal Article
Closed access
PDF file
Manuela CervelliManuela Cervelli
Manuela Cervelli
DSDaniele Salvi
Daniele Salvi
Fabio PolticelliFabio Polticelli
Fabio Polticelli
RARoberto Amendola
Roberto Amendola
Paolo MariottiniPaolo Mariottini
Paolo Mariottini

10 August 2013 in Amino Acids
Verified
Journal Article
Closed access
PDF file
Manuela CervelliManuela Cervelli
Manuela Cervelli
EAEmanuela Angelucci
Emanuela Angelucci
FGFederico Germani
Federico Germani
RARoberto Amendola
Roberto Amendola
Paolo MariottiniPaolo Mariottini
Paolo Mariottini

21 July 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Manuela CervelliManuela Cervelli
Manuela Cervelli
MONICA AVERNAMONICA AVERNA
MONICA AVERNA
LVLaura Vergani
Laura Vergani
Marco PedrazziMarco Pedrazzi
Marco Pedrazzi
SASarah Amato
Sarah Amato
MMManuela Marcoli
Manuela Marcoli
In mammalian cells, the content of polyamines is tightly regulated. Polyamines, including spermine, spermidine and putrescine, are involved in many cellular processes. Spermine oxidase specifically oxidizes spermine, and its deregulated activity has been reported to be linked to brain pathologies involving neuron damage. Spermine is a neuromodulator of a number of ionotropic glutamate receptors and types of ion channels. In this respect, the Dach-SMOX mouse model overexpressing spermine oxidase in the neocortex neurons was revealed to be a model of chronic oxidative stress, excitotoxicity and neuronal damage. Reactive astrocytosis, chronic oxidative and excitotoxic stress, neuron loss and the susceptibility to seizure in the Dach-SMOX are discussed here. This genetic model would help researchers understand the linkage between polyamine dysregulation and neurodegeneration and unveil the roles of polyamines in the crosstalk between astrocytes and neurons in neuroprotection or neurodegeneration.

3 November 2015 in NeuroMolecular Medicine
Verified
Journal Article
Closed access
PDF file
Chiara CervettoChiara Cervetto
Chiara Cervetto
LVLaura Vergani
Laura Vergani
MPMario Passalacqua
Mario Passalacqua
MRMilena Ragazzoni
Milena Ragazzoni
AVArianna Venturini
Arianna Venturini
Manuela CervelliManuela Cervelli
Manuela Cervelli

14 February 2018 in Medical Sciences
Verified
Journal Article
Open access
PDF file
Manuela CervelliManuela Cervelli
Manuela Cervelli
ALAlessia Leonetti
Alessia Leonetti
Guglielmo DurantiGuglielmo Duranti
Guglielmo Duranti
SSStefania Sabatini
Stefania Sabatini
Roberta CeciRoberta Ceci
Roberta Ceci
Paolo MariottiniPaolo Mariottini
Paolo Mariottini
Skeletal muscle comprises approximately 40% of the total body mass. Preserving muscle health and function is essential for the entire body in order to counteract chronic diseases such as type II diabetes, cardiovascular diseases, and cancer. Prolonged physical inactivity, particularly among the elderly, causes muscle atrophy, a pathological state with adverse outcomes such as poor quality of life, physical disability, and high mortality. In murine skeletal muscle C2C12 cells, increased expression of the spermine oxidase (SMOX) enzyme has been found during cell differentiation. Notably, SMOX overexpression increases muscle fiber size, while SMOX reduction was enough to induce muscle atrophy in multiple murine models. Of note, the SMOX reaction product spermidine appears to be involved in skeletal muscle atrophy/hypertrophy. It is effective in reactivating autophagy, ameliorating the myopathic defects of collagen VI-null mice. Moreover, spermidine treatment, if combined with exercise, can affect D-gal-induced aging-related skeletal muscle atrophy. This review hypothesizes a role for SMOX during skeletal muscle differentiation and outlines its role and that of spermidine in muscle atrophy. The identification of new molecular pathways involved in the maintenance of skeletal muscle health could be beneficial in developing novel therapeutic lead compounds to treat muscle atrophy.

3 February 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SPStefano Pietropaoli
Stefano Pietropaoli
ALAlessia Leonetti
Alessia Leonetti
CCChiara Cervetto
Chiara Cervetto
AVArianna Venturini
Arianna Venturini
RMRoberta Mastrantonio
Roberta Mastrantonio
Manuela CervelliManuela Cervelli
Manuela Cervelli